Vimarsana
Biggest News Aggregation in the World

Page 3 - Common Rule News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Common Rule. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Common Rule Today - Breaking & Trending Today

Key Information and Facilitating Understanding in Informed Consent Guidance for Sponsors, Investigators, and Institutional Review Boards - Vimarsana News

Key Information and Facilitating Understanding in Informed Consent Guidance for Sponsors, Investigators, and Institutional Review Boards

Key Information and Facilitating Understanding in Informed Consent Guidance for Sponsors, Investigators, and Institutional Review Boards

Source: fda.gov
NIST Researchers Suggest Historical Precedent for Ethical AI Research - Vimarsana News

NIST Researchers Suggest Historical Precedent for Ethical AI Research

The Belmont Report’s guidelines could help avoid repeating past mistakes in AI-related human subjects research.

Source: nist.gov
Understanding the requirements for waiving or altering HIPAA authorization for research | Health Care Compliance Association (HCCA) - Vimarsana News

Understanding the requirements for waiving or altering HIPAA authorization for research | Health Care Compliance Association (HCCA)

The HIPAA Privacy Rule sets forth provisions related to the waiver or alteration of authorization in relation to clinical research studies for circumstances in which it would be...

In This Month's E-News: February 2024 | Health Care Compliance Association (HCCA) - Vimarsana News

In This Month's E-News: February 2024 | Health Care Compliance Association (HCCA)

The Food and Drug Administration (FDA) is seeking strategies from Jeffrey W. Taub, M.D., to prevent future violations of human subject regulations the agency said were documented during...

FDA Final Rule: IRB Waiver Of Informed Consent For Minimal-Risk Investigations - Food and Drugs Law - Vimarsana News

FDA Final Rule: IRB Waiver Of Informed Consent For Minimal-Risk Investigations - Food and Drugs Law

The Food and Drug Administration expands informed consent exceptions with a final rule permitting institutional review board waiver or alteration of elements for certain FDA-regulated minimal-risk clinical investigations.

Source: mondaq.com